Trinity Biotech Provides an Update on the Continued Development of Its Continuous Glucose Monitor Technology

Stock Information for Trinity Biotech plc

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Trinity Biotech plc

Trinity Biotech to Initiate CGM Market Study in India in Furtherance of Intended Collaboration with Bayer
Trinity Biotech Appoints Global Life Sciences Leader as Chief Commercial Officer
Trinity Biotech Announces Increased Orders for TrinScreen HIV and Raises Guidance For 2024 Sales
Trinity Biotech Appoints Diabetes Care Veteran as Biosensor Marketing Director
Trinity Biotech Announces Q2 2024 Financial Results
Trinity Biotech to Announce Q2 2024 Financial Results
Trinity Biotech Obtains an Extension to Demonstrate Compliance With Nasdaq Listing Requirements
Trinity Biotech Provides Preliminary Second Quarter 2024 Update and Enters into UK Distribution Agreement with MedScience

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.